Algernon Pharmaceuticals Stock Probability of Future OTC Stock Price Finishing Over 0.0576
| AGNPF Stock | USD 0.06 0 3.16% |
Algernon |
Algernon Pharmaceuticals Target Price Odds to finish over 0.0576
The tendency of Algernon OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above $ 0.06 in 90 days |
| 0.06 | 90 days | 0.06 | about 74.86 |
Based on a normal probability distribution, the odds of Algernon Pharmaceuticals to stay above $ 0.06 in 90 days from now is about 74.86 (This Algernon Pharmaceuticals probability density function shows the probability of Algernon OTC Stock to fall within a particular range of prices over 90 days) . Probability of Algernon Pharmaceuticals price to stay between $ 0.06 and its current price of $0.0588 at the end of the 90-day period is under 4.
Assuming the 90 days horizon Algernon Pharmaceuticals has a beta of -0.95. This suggests Additionally Algernon Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Algernon Pharmaceuticals Price Density |
| Price |
Predictive Modules for Algernon Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Algernon Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Algernon Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Algernon Pharmaceuticals is not an exception. The market had few large corrections towards the Algernon Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Algernon Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Algernon Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.03 | |
β | Beta against Dow Jones | -0.95 | |
σ | Overall volatility | 0.01 | |
Ir | Information ratio | -0.02 |
Algernon Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Algernon Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Algernon Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Algernon Pharmaceuticals generated a negative expected return over the last 90 days | |
| Algernon Pharmaceuticals has high historical volatility and very poor performance | |
| Algernon Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Algernon Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (6.05 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Algernon Pharmaceuticals has accumulated about 872.84 K in cash with (2.91 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.44, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Algernon Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Algernon OTC Stock often depends not only on the future outlook of the current and potential Algernon Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Algernon Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2.4 M |
Algernon Pharmaceuticals Technical Analysis
Algernon Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Algernon OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Algernon Pharmaceuticals. In general, you should focus on analyzing Algernon OTC Stock price patterns and their correlations with different microeconomic environments and drivers.
Algernon Pharmaceuticals Predictive Forecast Models
Algernon Pharmaceuticals' time-series forecasting models is one of many Algernon Pharmaceuticals' otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Algernon Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.
Things to note about Algernon Pharmaceuticals
Checking the ongoing alerts about Algernon Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Algernon Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Algernon Pharmaceuticals generated a negative expected return over the last 90 days | |
| Algernon Pharmaceuticals has high historical volatility and very poor performance | |
| Algernon Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Algernon Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (6.05 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Algernon Pharmaceuticals has accumulated about 872.84 K in cash with (2.91 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.44, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Other Information on Investing in Algernon OTC Stock
Algernon Pharmaceuticals financial ratios help investors to determine whether Algernon OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Algernon with respect to the benefits of owning Algernon Pharmaceuticals security.